SAN FRANCISCO, April 19, 2019 /PRNewswire/ -- Since the CRISPR genome editing technology was invented in 2012, it has shown great promise to treat a number of intractable diseases. However, scientists have struggled to identify potential off-target effects in therapeutically relevant cell ...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]fects-of-crispr-300835202.html